APA (7th ed.) Citation

Singh, K. (2023, January). Rezvilutamide for metastatic castration-sensitive prostate cancer: CHART trial. Indian Journal of Urology.

Chicago Style (17th ed.) Citation

Singh, Kirti. "Rezvilutamide for Metastatic Castration-sensitive Prostate Cancer: CHART Trial." Indian Journal of Urology Jan. 2023.

MLA (9th ed.) Citation

Singh, Kirti. "Rezvilutamide for Metastatic Castration-sensitive Prostate Cancer: CHART Trial." Indian Journal of Urology, Jan. 2023.